News
-
-
PRESS RELEASE
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
StageZero Life Sciences, Ltd. announces a delay in filing its audited financial statements for 2023, cites financial resource constraints. Company applies for Management Cease Trade Order from Ontario Securities Commission -
-
-
-